scholarly article | Q13442814 |
P356 | DOI | 10.1016/0090-6980(89)90019-1 |
P698 | PubMed publication ID | 2748922 |
P2093 | author name string | K Kato | |
H Kuriki | |||
T Matsumoto | |||
Y Ashida | |||
M Shiraishi | |||
S Terao | |||
P433 | issue | 1 | |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 91-112 | |
P577 | publication date | 1989-07-01 | |
P1433 | published in | Prostaglandins | Q24054793 |
P1476 | title | A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids | |
P478 | volume | 38 |
Q77750849 | Binding of YM158, a new dual antagonist for leukotriene D4 and thromboxane A2 receptors, to guinea pig lung membranes |
Q42617977 | Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients? |
Q71943096 | Characterization of thromboxane A2/prostaglandin endoperoxide receptors in aorta |
Q43686899 | Effect of AA-2414 on early and late bronchial responses in actively sensitized guinea-pigs |
Q77846743 | Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma |
Q41948877 | Effect of Oral Administration of A Prostacyclin Analog (Op-41483) On Pulmonary Function and Bronchial Responsiveness in Stable Asthmatic Subjects |
Q74416799 | Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma |
Q46224022 | Effect of the prostaglandin endoperoxide antagonist AA-2414 on experimental allergic asthma |
Q42275226 | Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs |
Q43588209 | Effects of eicosanoids on lipopolysaccharide-induced ornithine decarboxylase activity and polyamine metabolism in the mouse liver |
Q37995534 | Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke |
Q74365677 | High-performance liquid chromatographic determination of seratrodast and its metabolites in human serum and urine |
Q74593919 | In vitro responses to antigen stimulation: comparison between human lung parenchyma resected from asthmatic patients and non-asthmatic patients |
Q53855607 | Interaction of thromboxane A2 and leukotrienes in guinea pig airways in vivo |
Q40694235 | Leukotriene and thromboxane antagonists |
Q36352924 | Novel and emerging therapies for asthma |
Q73846485 | Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma |
Q50916463 | Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection. |
Q33485483 | Prostanoid receptor antagonists: development strategies and therapeutic applications |
Q57480566 | Seratrodast (AA-2414)?A Novel Thromboxane-A2Receptor Antagonist |
Q44546106 | The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle |
Q34289502 | Thromboxane A2 inhibition: therapeutic potential in bronchial asthma |
Q37113049 | Thromboxane A2 receptor antagonists |
Q37953820 | Thromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting. |
Search more.